These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1207939)

  • 1. [Therapeutic activity and gastric tolerance of a corticosteroid associated with a gastroprotective drug].
    Saccabusi E
    Minerva Gastroenterol; 1975; 21(1):35-44. PubMed ID: 1207939
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic value of the combination of a corticosteroid (prednisone) with a gastroprotective substance (xylamide)].
    Abbona C; Marugo M; Berretti A
    Minerva Med; 1972 Sep; 63(60):3258-65. PubMed ID: 4559865
    [No Abstract]   [Full Text] [Related]  

  • 3. [Controlled clinical trial of a preparation with steroid activity (prednisone) associated with xylamide, protective drug for the gastric mucosa].
    Jezzi B
    Minerva Med; 1972 Sep; 63(67):3659-66. PubMed ID: 5071475
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled clinical trial a gastroprotective steroid (prednisone + xylamide)].
    D'Elia A; Colella C; Contursi R
    Minerva Med; 1972 Sep; 63(65):3554-8. PubMed ID: 4627381
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic value of an antigastrin nonatropinic antisecretory drug in esogastroduodenal pathology].
    Trepo C; Sambin P
    Med Chir Dig; 1978; 7(5):447-51. PubMed ID: 723323
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proglumide in peptic ulcer and in gastroduodenal pathology. Clinical, biological and endoscopic study].
    Bennani A
    Med Chir Dig; 1979; 8(4):351-6. PubMed ID: 502629
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of a drug with steroid activity combined with a gastroprotective substance].
    Saccabusi E
    Minerva Med; 1972 Sep; 63(62):3395-401. PubMed ID: 5056315
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ulcer therapy with the gastrin receptor antagonist proglumide. Results of the field study].
    Rehner M; Asshauer E
    Med Welt; 1981 May; 32(20):792-4. PubMed ID: 6267407
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats.
    Tariq M; Parmar NS; Ageel AM
    J Pharmacol Exp Ther; 1987 May; 241(2):602-7. PubMed ID: 3572816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of proglumide on gastric motility].
    Mazzone O; Monello S; Trovato GM; MandalĂ  ML; Di Frazzio S
    Clin Ter; 1981 Jan; 96(1):25-30. PubMed ID: 7237946
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind comparison of the antirheumatic activity and gastric side-effects of indomethacin used alone or in combination with a gastro-protective agent, proglumide.
    Pipitone V
    Curr Med Res Opin; 1976; 4(4):267-77. PubMed ID: 791585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of peptic ulcer with milide (proglumide)].
    Brailski Kh; Mendizova A; Dimitrov B; Vladimirov B; Koparanova A
    Klin Med (Mosk); 1989 Mar; 67(3):104-6. PubMed ID: 2664333
    [No Abstract]   [Full Text] [Related]  

  • 13. [Two-year study on incidence of ulcer recurrence following proglumide therapy. A comparative study].
    Galeone M; Moise G; Casula PL; Bignamini AA
    Med Welt; 1981 Jan; 32(5):173-5. PubMed ID: 7207154
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled and double-blind study of the treatment of peptic ulcer with cimetidine and proglumide].
    Volpi C; Dellepiane F; Michetti P; Testa R
    Clin Ter; 1980 May; 93(4):417-29. PubMed ID: 6998642
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid-adrenocortical relationships in the safe treatment of arthritis, allergy, and skin disorders with prednisone.
    Barnes BO
    J Am Geriatr Soc; 1975 Dec; 23(12):548-50. PubMed ID: 1206190
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glucocorticoid therapy of acute viral hepatitis and of its sequelae].
    Kommerell B; Schettler G
    Munch Med Wochenschr; 1969 Jan; 111(4):180-5. PubMed ID: 5305037
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastrointestinal events related to the use of non-steroidal anti-inflammatory drugs: some clinical and economic aspects.
    Eliakim R; Rachmilewitz D
    Isr J Med Sci; 1997 Oct; 33(10):696-9. PubMed ID: 9397147
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gastrointestinal complications and gastric juice secretion before and after kidney transplantation].
    Vetter D; Zaruba K; Scheitlin W
    Schweiz Med Wochenschr; 1971 Dec; 101(52):1893-8. PubMed ID: 4946652
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
    Price DD; von der Gruen A; Miller J; Rafii A; Price C
    Anesth Analg; 1985 Aug; 64(8):801-6. PubMed ID: 4014744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users.
    Murthy SK; Kauldher S; Targownik LE
    Aliment Pharmacol Ther; 2006 May; 23(9):1365-72. PubMed ID: 16629943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.